ArticleJournal of imaging2026
Brain Tumor Classification in MRI Images Using Combined Transfer Learning and Convolutional Neural Networks.
Article in Journal of imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Early and accurate brain tumor detection is vital for effective treatment. We propose a deep learning framework for MRI-based brain tumor classification, featuring a novel Custom CNN evaluated independently alongside six pre-trained models for comparative analysis (InceptionV3, EfficientNetV2L, ResNet152V2, Xception, VGG16, and MobileNetV2). Additionally, three separate ensemble models are constructed to analyze whether model combination improves performance. Experiments conducted on the Kaggle-Multiclass brain MRI dataset show that the proposed Custom CNN achieves the best performance, with an accuracy of 99.54%, and features a task-specific architecture (0.57M parameters) that achieves superior performance through domain-specific feature learning and computational efficiency, thus outperforming both individual pre-trained models and ensemble approaches. Among pre-trained models, EfficientNetV2L (99.47%) and InceptionV3 (99.39%) show competitive results, while the best ensemble model achieves 99.47% accuracy, indicating clinical deployment potential pending external validation. These results demonstrate that the proposed Custom CNN provides superior performance without requiring ensemble complexity, thus highlighting its effectiveness and efficiency for automated brain tumor classification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.